Advertisement

Topics

Lilly dips as biomed chief Christi Shaw heads to Gilead

04:26 EDT 12 Jul 2019 | pharmaphorum

Christi Shaw, president of Eli Lilly Bio-Medicines is leaving the company after two years, taking the top job at Gilead's Kite cancer immunotherapy unit. Shares in Lilly were down almost 4% after the announcement, which also revealed that Lilly’s ...

Original Article: Lilly dips as biomed chief Christi Shaw heads to Gilead

NEXT ARTICLE

More From BioPortfolio on "Lilly dips as biomed chief Christi Shaw heads to Gilead"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...